Quinapril and Hyperthyroid - a phase IV clinical study of FDA data

Summary:

Hyperthyroid is reported as a side effect among people who take Quinapril (quinapril hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Brilinta, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Hyperthyroid when taking Quinapril. It is created by eHealthMe based on reports of 12,572 people who have side effects when taking Quinapril from the FDA, and is updated regularly.

What is Quinapril?

Quinapril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 12,927 Quinapril users. Check the latest studies of Quinapril.

What is Hyperthyroid?

Hyperthyroid is found to be associated with 1,142 drugs and 1,401 conditions by eHealthMe. Check the latest studies of Hyperthyroid.

On Dec, 01, 2025

12,572 people reported to have side effects when taking Quinapril.
Among them, 11 people (0.09%) have Hyperthyroid.

Among these 11 people:

How long have people been on Quinapril when they have Hyperthyroid? *

What is the gender of people who have Hyperthyroid when taking Quinapril? *

female: 80 %
male: 20 %

What is the age of people who have Hyperthyroid when taking Quinapril? *

What are other drugs people take besides Quinapril? *

What are other side effects people have besides Hyperthyroid? *

Rickets (softening of bones): 3 people, 27.27%
Weight Decreased: 3 people, 27.27%
Scab (a hard coating on the skin formed during the wound healing): 2 people, 18.18%
Bleeding Into The Skin: 2 people, 18.18%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
Insulin-Like Growth Factor Increased: 2 people, 18.18%
Renal Disorder (kidney disease): 2 people, 18.18%
Head Injury: 2 people, 18.18%
Dizziness: 1 person, 9.09%
Dopamine Dysregulation Syndrome (complication of the dopaminergic treatment in parkinson's disease): 1 person, 9.09%

What are the existing conditions these people have? *

Type 2 Diabetes: 3 people, 27.27%
Sleep Disorder: 2 people, 18.18%
High Blood Cholesterol: 2 people, 18.18%
Ulcer Haemorrhage (bleeding ulcer): 1 person, 9.09%
Quit Smoking: 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 9.09%
Muscle Spasms (muscle contraction): 1 person, 9.09%
Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Quinapril and have Hyperthyroid?

- Check whether Hyperthyroid is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Quinapril:

Quinapril (12,927 reports)

Hyperthyroid treatments and more:

Hyperthyroid (26,828 reports)

Browse all side effects of Quinapril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroid:

Hyperthyroid (1,142 drugs)

Browse all the conditions that are associated with Hyperthyroid:

Hyperthyroid (1,401 conditions)

Drugs similar to Quinapril and Hyperthyroid :

How the study uses the data?

The study uses data from the FDA. It is based on quinapril hydrochloride (the active ingredients of Quinapril) and Quinapril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.